Compound Evidence File
#EC-2026-0267
Equipoise (Boldenone Undecylenate)
Filed under Injectable Oils. The bureau holds 162 laboratory returns for this compound from 57 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
57 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 9.9 | 10.0 | 17 Feb 2026 | 13 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 25 Jan 2026 | 4 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 10.0 | 10.0 | 12 Dec 2025 | 8 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 9.9 | 10.0 | 4 Apr 2026 | 16 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Dec 2025 | 22 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 10.0 | 10.0 | 10.0 | 2 Mar 2026 | 18 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 1 May 2026 | 19 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 10.0 | 10.0 | 10.0 | 19 Apr 2026 | 26 May 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 10.0 | 10.0 | 10.0 | 17 Mar 2026 | 11 Apr 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 10.0 | 10.0 | 10.0 | 19 Jul 2026 | 21 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 7 Apr 2026 | 28 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 7 Nov 2025 | 16 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 23 Nov 2025 | 4 Apr 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 9.9 | 9.9 | 10.0 | 24 Dec 2025 | 15 Aug 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 9.9 | 9.9 | 10.0 | 22 May 2026 | 19 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 10 Mar 2026 | 9 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 9.9 | 9.9 | 9.9 | 20 Jun 2026 | 16 Aug 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 10.0 | 1 Feb 2026 | 27 Feb 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 10.0 | 3 Feb 2026 | 23 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 10.0 | 16 Jul 2026 | 1 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 8 Jan 2026 | 4 Apr 2026 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 9.4 | 9.4 | 9.4 | 25 Apr 2025 | 25 Apr 2025 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 8.8 | 8.8 | 8.8 | 27 Feb 2025 | 27 Feb 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.7 | 7.8 | 10.0 | 25 May 2026 | 25 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 8.7 | 7.4 | 10.0 | 23 May 2026 | 23 May 2026 |
| ZhuoYan labCASE #VI-2026-0902 | X | 2 | 8.6 | 7.9 | 9.3 | 6 May 2025 | 17 May 2026 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | X | 1 | 8.4 | 8.4 | 8.4 | 21 May 2025 | 21 May 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 8.1 | 8.1 | 8.1 | 16 Mar 2025 | 16 Mar 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 8.0 | 7.2 | 9.0 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.0 | 6.1 | 9.5 | 21 May 2026 | 21 May 2026 |
| Alpha-GenCASE #VI-2026-0905 | X | 3 | 7.9 | 6.3 | 9.3 | 28 Mar 2025 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 3 | 7.7 | 6.9 | 8.9 | 24 May 2026 | 24 May 2026 |
| YimeiCASE #VI-2026-0081 | X | 4 | 7.2 | 5.5 | 8.7 | 27 Feb 2025 | 21 May 2026 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 7.0 | 7.0 | 7.0 | 6 May 2025 | 6 May 2025 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 7.0 | 7.0 | 7.0 | 20 Jun 2025 | 20 Jun 2025 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 6.6 | 6.6 | 6.6 | 28 Mar 2025 | 28 Mar 2025 |
| SRY LabsCASE #VI-2026-0657 | X | 8 | 6.5 | 4.4 | 10.0 | 27 Feb 2025 | 19 Jan 2026 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 6.5 | 6.5 | 6.5 | 13 Feb 2025 | 13 Feb 2025 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 6.4 | 6.4 | 6.4 | 2 Jul 2025 | 2 Jul 2025 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 1 | 6.3 | 6.3 | 6.3 | 20 Jun 2025 | 20 Jun 2025 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | X | 6 | 6.1 | 2.4 | 8.0 | 28 Mar 2025 | 20 May 2026 |
| LSPLCASE #VI-2026-0523 | X | 3 | 5.9 | 3.5 | 7.4 | 24 Apr 2025 | 20 May 2026 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | X | 2 | 5.8 | 4.2 | 7.4 | 24 Apr 2025 | 23 May 2026 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 5.4 | 5.4 | 5.4 | 6 May 2025 | 6 May 2025 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 5.4 | 5.4 | 5.4 | 24 Apr 2025 | 24 Apr 2025 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 5.4 | 5.4 | 5.4 | 8 Jul 2025 | 8 Jul 2025 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 5.1 | 5.1 | 5.1 | 13 Jun 2025 | 13 Jun 2025 |
| ScienceCASE #VI-2026-0636 | X | 1 | 5.0 | 5.0 | 5.0 | 13 Feb 2025 | 13 Feb 2025 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 2 | 4.2 | 2.3 | 6.2 | 16 Mar 2025 | 25 May 2026 |
| DeuschemCASE #VI-2026-0004 | X | 2 | 4.1 | 1.9 | 6.3 | 21 May 2025 | 26 Jan 2026 |
| Elite Research USACASE #VI-2026-0267 | X | 4 | 4.0 | 2.3 | 6.1 | 3 Jul 2025 | 21 May 2026 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 3.7 | 3.7 | 3.7 | 14 Jan 2025 | 14 Jan 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 0.1 | 0.1 | 0.1 | 13 Jun 2025 | 13 Jun 2025 |
| SubQ SocietyCASE #VI-2026-0716 | X | 1 | 0.0 | 0.0 | 0.0 | 2 Jul 2025 | 2 Jul 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 0.0 | 0.0 | 0.0 | 7 May 2025 | 7 May 2025 |
Open any subject to view the batch-level evidence for Equipoise (Boldenone Undecylenate) alone.